--(www.USEquityNews.com)-- 11/27/2007 - Pharmaceutical industry alert provided by U.S. Equity News. XOMA, Ltd., (NASDAQ: XOMA), a leader in the discovery and development of antibody therapeutics, recently will host a conference call and live webcast to discuss its business strategy including an overview of its clinical development plans and 2008 outlook. The conference call and webcast will take place at 5:00 p.m. Eastern time with XOMA management, and will be followed by a question and answer session.
InterMune Inc. bought the rights to a drug candidate it had licensed from Marnac Inc. and KDL GmbH. The Brisbane company (NASDAQ: ITMN) bought rights to the patents for pirfenidone, a treatment being tested for idiopathic pulmonary fibrosis, or IPF, for an upfront payment of $13.5 million. It also agreed to pay more -- up to $53.5 million -- if the drug tests well in Phase III trials and is approved by regulators.
Pharmacopeia (NASDAQ: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, recently announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the seventh annual Focus on Healthcare Conference hosted by BMO Capital Markets. The conference will be held December 4-5, 2007, at the Millennium Broadway Hotel in New York City. Dr. Browne's presentation will take place at 3:30 p.m. EST on Tuesday, December 4th.
Aida Pharmaceuticals, Inc. (OTCBB: AIDA) recently announced that it has filed its form 10Q for the period ended September 30, 2007. Net revenues totaled $7,373,770 for the quarter ended 9/20/07, an increase of 5% over the same period in 2006. Gross profit decreased by 2.66% due to an increase in Costs of Goods Sold. Most notably, sales from Aida's transfusion and injection forms of etimicin sulfate increased markedly.
About U.S. Equity News
U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.
U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com.
